Brentuximab for second-line lymphoma treatment

Relapsed & refractory classic Hodgkin lymphomaПодробнее

Relapsed & refractory classic Hodgkin lymphoma

Debate: Best second line therapy for relapsed Hodgkin lymphoma - Brentuximab alone/+ chemoПодробнее

Debate: Best second line therapy for relapsed Hodgkin lymphoma - Brentuximab alone/+ chemo

First Line Treatment of CLLПодробнее

First Line Treatment of CLL

Alex Herrera on Nivolumab/Brentuximab Vedotin Combination for Patients with Hodgkin LymphomaПодробнее

Alex Herrera on Nivolumab/Brentuximab Vedotin Combination for Patients with Hodgkin Lymphoma

Hodgkin LymphomaПодробнее

Hodgkin Lymphoma

Update on Peripheral T-Cell Lymphoma Webinar | LRF WebinarsПодробнее

Update on Peripheral T-Cell Lymphoma Webinar | LRF Webinars

Debate: Recurrent Hodgkin's lymphoma after ASCT in CR on brentuximab vedotin - MaintenanceПодробнее

Debate: Recurrent Hodgkin's lymphoma after ASCT in CR on brentuximab vedotin - Maintenance

Debate: Best Second-line Approach to Induce Lymphoma Remission Prior to SCT? - ChemotherapyПодробнее

Debate: Best Second-line Approach to Induce Lymphoma Remission Prior to SCT? - Chemotherapy

What’s new in the initial management of Hodgkin lymphoma?Подробнее

What’s new in the initial management of Hodgkin lymphoma?

Debate: Best Second-line Approach to Induce Lymphoma Remission Prior to SCT? - BrentuximabПодробнее

Debate: Best Second-line Approach to Induce Lymphoma Remission Prior to SCT? - Brentuximab

T-cell LymphomaПодробнее

T-cell Lymphoma

Mantle Cell Lymphoma (Case Studies)Подробнее

Mantle Cell Lymphoma (Case Studies)